PREDNISONE- prednisone tablet

Valsts: Amerikas Savienotās Valstis

Valoda: angļu

Klimata pārmaiņas: NLM (National Library of Medicine)

Aktīvā sastāvdaļa:

PREDNISONE (UNII: VB0R961HZT) (PREDNISONE - UNII:VB0R961HZT)

Pieejams no:

Safecor Health, LLC

SNN (starptautisko nepatentēto nosaukumu):

PREDNISONE

Kompozīcija:

PREDNISONE 20 mg

Ievadīšanas:

ORAL

Receptes veids:

PRESCRIPTION DRUG

Ārstēšanas norādes:

Prednisone Tablets, USP are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) Congenital adrenal hyperplasia Nonsuppurative thyroiditis 2. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Psoriatic arthritis Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) Ankylosing spondylitis Acute and subacute bursitis Acute nonspecific tenosynovitis Acute gouty arthritis Post-traumatic osteoarthritis Synovitis of osteoarthritis Epicondylitis. 3. Collagen Diseases During an exacerbation or as maintenance therapy in selected cases of: Systemic lupus erythematosus Systemic derznatomyositis

Produktu pārskats:

Prednisone Tablets, USP are available in the following strengths and package sizes: 20mg (peach, round, scored, imprinted with TL175)           Box of 100, Unit Dose Robot-Rx ®1 Tablets   NDC 48433-321-01 For Institutional Use Only Store at 20° to 25° C (68° to 77° F) [See USP Room Temperature] The product contained in this package is from NDC# 59746-0175 Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA. Packaged and Distributed by: Safecor Health, LLC 4060 Business Park Drive Columbus, OH 43204 Safecor Health, LLC 317 New Boston Street Woburn, MA 01801 Questions and Comments? Call 1-800-447-1006 Rev: 321-00 08/2014

Autorizācija statuss:

Abbreviated New Drug Application

Produkta apraksts

PREDNISONE- PREDNISONE TABLET
SAFECOR HEALTH, LLC
----------
PREDNISONE TABLETS, USP
RX ONLY
DESCRIPTION
Prednisone is a glucocorticoid. Glucocorticoids are adrenocortical
steroids, both naturally occurring
and synthetic, which are readily absorbed from the gastrointestinal
tract. Prednisone is a white to
practically white, odorless, crystalline powder. It is very slightly
soluble in water; slightly soluble in
alcohol, in chloroform, in dioxane, and in methanol. The chemical name
for prednisone is pregna-1, 4-
diene-3, 11, 20-trione, 17, 21-dihydroxy-
The structural formula is represented below:
Molecular weight: 358.44
Prednisone Tablets, USP are available in three strengths: 5 mg, 10 mg,
and 20 mg. In addition, each
tablet contains the following Inactive Ingredients: Lactose
Monohydrate, Magnesium Stearate,
Pregelatinized Starch, Sodium Lauryl Sulfate and Sodium Starch
Glycolate. Also Prednisone Tablets
USP, 20 mg contains FD & C yellow #6 aluminum lake HT 15-18%.
ACTIONS
Naturally occurring glucocorticoids (hydrocortisone and cortisone),
which also have salt-retaining
properties, are used as replacement therapy in adrenocortical
deficiency states. Their synthetic analogs
are primarily used for their potent anti-inflammatory effects in
disorders of many organ systems.
Glucocorticoids cause profound and varied metabolic effects. In
addition, they modify the body's
immune responses to diverse stimuli.
INDICATIONS
Prednisone Tablets, USP are indicated in the following conditions:
1. ENDOCRINE DISORDERS
Primary or secondary adrenocortical insufficiency (hydrocortisone or
cortisone is the first choice;
synthetic analogs may be used in conjunction with mineralocorticoids
where applicable; in infancy
mineralocorticoid supplementation is of particular importance)
Congenital adrenal hyperplasia
Nonsuppurative thyroiditis
2. RHEUMATIC DISORDERS
As adjunctive therapy for short-term administration (to tide the
patient over an acute episode or
exacerbation) in:
Psoriatic arthritis
Rheumatoid arthritis, including juvenile rh